These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1794262)

  • 41. Diabetic retinopathy in non-insulin-dependent diabetes mellitus patients: the role of gliclazide.
    Akanuma Y; Kosaka K; Kanazawa Y; Kasuga M; Fukuda M; Aoki S
    Am J Med; 1991 Jun; 90(6A):74S-76S. PubMed ID: 1872308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of the combination of insulin and gliclazide compared with insulin alone in type 2 diabetic patients with secondary failure to oral hypoglycemic agents.
    Aschner P; Kattah W
    Diabetes Res Clin Pract; 1992 Oct; 18(1):23-30. PubMed ID: 1446575
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hypoglycemic and microvascular properties of gliclazide: a review of the latest international studies].
    Lesobre B
    Sem Hop; 1983 Jun; 59(24):1827-33. PubMed ID: 6308816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of 6 months' gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial CSII-induced normoglycemia.
    Della Casa L; del Rio G; Glaser B; Cerasi E
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S69-78. PubMed ID: 1794269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Home blood glucose monitoring in non-insulin-dependent diabetics: the effect of gliclazide on blood glucose and weight control, a multicentre trial.
    Shaw KM; Wheeley MS; Campbell DB; Ward JD
    Diabet Med; 1985 Nov; 2(6):484-90. PubMed ID: 2951123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of sulphonylurea administration on insulin secretion and amino acid metabolism in non-insulin-dependent diabetic patients.
    Paterson KR; Gyi KM; McBride D; Cohen HN; Shenkin A; Manderson WG; MacCuish AC
    Diabet Med; 1985 Jan; 2(1):38-40. PubMed ID: 2951064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of short term hypoglycemic treatment with gliclazide and gliquidone on platelet function in patients with diabetes mellitus type II].
    Grzeszczak W; Strojek K
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():38-9. PubMed ID: 8516206
    [No Abstract]   [Full Text] [Related]  

  • 48. Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.
    Bo S; Castiglione A; Ghigo E; Gentile L; Durazzo M; Cavallo-Perin P; Ciccone G
    Eur J Endocrinol; 2013 Jul; 169(1):117-26. PubMed ID: 23660643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of gliclazide on platelet function in patients with diabetes mellitus.
    Violi F; De Mattia GC; Alessandri C; Perrone A; Vezza E
    Curr Med Res Opin; 1982; 8(3):200-3. PubMed ID: 7128193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of gliclazide on platelet-activating factor-induced platelet aggregation in patients with non-insulin-dependent diabetes mellitus.
    Phenekos C; Siafaka-Kapadai A; Trapali M; Botitsi E; Mavris M
    Metabolism; 1992 May; 41(5 Suppl 1):30-2. PubMed ID: 1574012
    [No Abstract]   [Full Text] [Related]  

  • 51. Glibenclamide vs gliclazide in type 2 diabetes of the elderly.
    Tessier D; Dawson K; Tétrault JP; Bravo G; Meneilly GS
    Diabet Med; 1994 Dec; 11(10):974-80. PubMed ID: 7895463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of an oral antidiabetic drug on the fibrinolytic system of blood in insulin-treated diabetic patients.
    Gram J; Jespersen J; Kold A
    Metabolism; 1988 Oct; 37(10):937-43. PubMed ID: 3050364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of gliclazide and glibenclamide on platelet function, fibrinolysis and metabolic control in diabetic patients with retinopathy (author's transl)].
    Chan TK; Chan V; Teng CS; Yeung RT
    Sem Hop; 1982 May; 58(19):1197-200. PubMed ID: 6285503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gliclazide treatment of streptozotocin diabetic rats restores GLUT4 protein content and basal glucose uptake in skeletal muscle.
    Pulido N; Suarez A; Casanova B; Romero R; Rodriguez E; Rovira A
    Metabolism; 1997 Dec; 46(12 Suppl 1):10-3. PubMed ID: 9439552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes.
    Chen LL; Yu F; Zeng TS; Liao YF; Li YM; Ding HC
    Eur J Pharmacol; 2011 Jun; 659(2-3):296-301. PubMed ID: 21453695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glimepiride. A review of its use in the management of type 2 diabetes mellitus.
    Langtry HD; Balfour JA
    Drugs; 1998 Apr; 55(4):563-84. PubMed ID: 9561345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-platelet effects of long-term treatment with gliclazide in diabetic patients.
    Ponari O; Civardi E; Megha S; Pini M; Portioli D; Dettori AG
    Thromb Res; 1979; 16(1-2):191-203. PubMed ID: 116387
    [No Abstract]   [Full Text] [Related]  

  • 58. [Medication of the month. Gliclazide modified release (Uni Diamicron)].
    Scheen AJ
    Rev Med Liege; 2003 Oct; 58(10):641-5. PubMed ID: 14677526
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Physiopathology of non insulin-dependent diabetes. Action of gliclazide].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1985; ():319-23. PubMed ID: 2577975
    [No Abstract]   [Full Text] [Related]  

  • 60. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.